| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 7 961-967, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
MA Rosenthal, MA Thompson, S Ellis, RH Whitehead and RG Ramsay
Ludwig Institute for Cancer Research, Tumor Biology Branch, Melbourne, Victoria, Australia.
c-myb expression is an indicator of hemopoietic cell proliferation and its down-regulation occurs as an early event in cellular differentiation in vitro. We have previously demonstrated c-Myb protein expression in normal adult colon and tumor-derived colonic cell lines and have also shown that the proliferation of colon carcinoma cell lines is c-myb dependent. This study used the techniques of RNase protection and immunohistochemistry to define c-myb mRNA and protein expression in the normal adult mouse and mouse embryos, with special focus on the colon. These experiments revealed wide-spread c-myb mRNA expression in mouse embryos including nonhemopoietic tissues, and developmental time course studies revealed alterations in organ-specific c-myb mRNA expression. Immunohistochemical studies confirmed the embryonal expression of c-Myb in concordance with the mRNA data as well as c-Myb expression throughout the length of the adult mouse colonic crypt. In contrast, staining for the proliferating cell nuclear antigen was confined to the lower one third of the crypt. In addition, c-Myb staining extended beyond that of the proliferating cell nuclear antigen within the germinal centers of the spleen. These data suggest that c-myb: (a) has a role in the embryonic development of nonhemopoietic organs; (b) plays a specific role in the biology of the normal adult colonic crypt; and (c) expression is not inextricably linked to proliferation in vivo.
This article has been cited by other articles:
![]() |
J. Malaterre, T. Mantamadiotis, S. Dworkin, S. Lightowler, Q. Yang, M. I. Ransome, A. M. Turnley, N. R. Nichols, N. R. Emambokus, J. Frampton, et al. c-Myb Is Required for Neural Progenitor Cell Proliferation and Maintenance of the Neural Stem Cell Niche in Adult Brain Stem Cells, January 1, 2008; 26(1): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Malaterre, M. Carpinelli, M. Ernst, W. Alexander, M. Cooke, S. Sutton, S. Dworkin, J. K. Heath, J. Frampton, G. McArthur, et al. c-Myb is required for progenitor cell homeostasis in colonic crypts PNAS, March 6, 2007; 104(10): 3829 - 3834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Ramsay, S. Micallef, S. Lightowler, M. L. Mucenski, T. Mantamadiotis, and I. Bertoncello c-myb Heterozygous Mice Are Hypersensitive to 5-Fluorouracil and Ionizing Radiation Mol. Cancer Res., June 1, 2004; 2(6): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, M. Inouye, E. R. Hines, J. F. Collins, and F. K. Ghishan Transcriptional regulation of the human NaPi-IIb cotransporter by EGF in Caco-2 cells involves c-myb Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1262 - C1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Andersson, E. Kowenz-Leutz, E. M. Brendeford, A.-H. H. Tygsett, A. Leutz, and O. S. Gabrielsen Phosphorylation-dependent Down-regulation of c-Myb DNA Binding Is Abrogated by a Point Mutation in the v-myb Oncogene J. Biol. Chem., January 31, 2003; 278(6): 3816 - 3824. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tanno, A. Negroni, R. Vitali, M. C. Pirozzoli, V. Cesi, C. Mancini, B. Calabretta, and G. Raschella Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms J. Biol. Chem., June 21, 2002; 277(26): 23172 - 23180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biroccio, B. Benassi, I. D'Agnano, C. D'Angelo, S. Buglioni, M. Mottolese, A. Ricciotti, G. Citro, M. Cosimelli, R. G. Ramsay, et al. c-Myb and Bcl-x Overexpression Predicts Poor Prognosis in Colorectal Cancer : Clinical and Experimental Findings Am. J. Pathol., April 1, 2001; 158(4): 1289 - 1299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |